QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?

References

• Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec’s cirrhosis. J. Clin. Invest.32, 1025–1033 (1953).
   PubMed Web of Science ®Google Scholar
• Wong F. Cirrhotic cardiomyopathy. Hepatol. Int.3, 294–304 (2009).
   PubMed Web of Science ®Google Scholar
• Zambruni A, Trevisani F, Caraceni P, Bernardi M. Cardiac electrophysiological abnormalities in patients with cirrhosis. J. Hepatol.44, 994–1002 (2006).
   PubMed Web of Science ®Google Scholar
• Rudy Y. Molecular basis of cardiac action potential repolarization. Ann. NY Acad. Sci.1123, 113–118 (2008).
   PubMed Web of Science ®Google Scholar
• Malik M, Farbom P, Batchvarov V, Hnatkova K, Camm AJ. Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart87, 220–228 (2002).
   PubMed Web of Science ®Google Scholar
• Malik M. The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes. Pacing Clin. Electrophysiol.25, 209–216 (2002).
   PubMed Web of Science ®Google Scholar
• Zambruni A, Di Micoli A, Lubisco A, Domenicali M, Trevisani F, Bernardi M. QT interval correction in patients with cirrhosis. J. Cardiovasc. Electrophysiol.18, 77–82 (2007).
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Kinirons MT, Swift CG, Jackson SH. Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis. Age Ageing32, 326–331 (2003).
   PubMed Web of Science ®Google Scholar
• Stramba-Badiale M, Locati EH, Martinelli A, Courville J, Schwartz PJ. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur. Heart J.18, 1000–1006 (1997).
   PubMed Web of Science ®Google Scholar
• Khan IA. Long QT syndrome: diagnosis and management. Am. Heart J.143, 7–14 (2002).
   PubMed Web of Science ®Google Scholar
• Roden DM. Drug-induced prolongation of the QT interval. N. Engl. J. Med.350, 1013–1022 (2004).
   PubMed Web of Science ®Google Scholar
• Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am. J. Med.112, 58–66 (2002).
   PubMed Web of Science ®Google Scholar
• Roden DM. Long QT syndrome. N. Engl. J. Med.358, 169–176 (2008).
   PubMed Web of Science ®Google Scholar
• Wang Q. Curran ME, Splawskin I et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet.12, 17–23 (1996).
   PubMed Web of Science ®Google Scholar
• Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation113, 1385–1392 (2006).
   PubMedGoogle Scholar
• Li EC, Esterly JS, Pohl S, Scott SD, McBride BF. Drug-induced QT-interval prolongation: considerations for clinicians. Pharmacotherapy30, 684–701 (2010).
   PubMed Web of Science ®Google Scholar
• Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell81, 299–307 (1995).
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhou Z, Gong Q, Makielski JC, January CT. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. Circ. Res.84, 989–998 (1999).
   PubMed Web of Science ®Google Scholar
• Day CP, James OF, Butler TJ, Campbell RW. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet341, 1423–1428 (1993).
   PubMed Web of Science ®Google Scholar
• Bernardi M, Calandra S, Colantoni A et al. Q–T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology27, 28–34 (1998).
   PubMed Web of Science ®Google Scholar
• Puthumana L, Chaudhry V, Thuluvath PJ. Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis. J. Hepatol.35, 733–738 (2001).
   PubMed Web of Science ®Google Scholar
• Bal JS, Thuluvath PJ. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int.23, 243–248 (2003).
   PubMed Web of Science ®Google Scholar
• Genovesi S, Prata Pizzala DM, Pozzi M et al. QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium. Clin. Sci. (Lond.)116, 851–859 (2009).
   PubMedGoogle Scholar
• Adigun AQ, Pinto AG, Flockhart DA et al. Effect of cirrhosis and liver transplantation on the gender difference in QT interval. Am. J. Cardiol.95, 691–694 (2005).
   PubMed Web of Science ®Google Scholar
• Mohamed R, Forsey PR, Davies MK, Neuberger J. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology23, 1128–1134 (1996).
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Gøtze JP, Fuglsang S, Christensen E, Bendtsen F, Moller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut52, 1511–1517 (2003).
   PubMed Web of Science ®Google Scholar
• Shin WJ, Kim YK, Song JG et al. Alterations in QT interval in patients undergoing living donor liver transplantation. Transplant. Proc.43, 170–173 (2011).
   PubMed Web of Science ®Google Scholar
• Ytting H, Henriksen JH, Fuglsang S, Bendtsen F. Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis. J. Hepatol.43, 637–644 (2005).
   PubMed Web of Science ®Google Scholar
• Trevisani F, Merli M, Savelli F et al. QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. J. Hepatol.38, 461–467 (2003).
   PubMed Web of Science ®Google Scholar
• Møller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart87, 9–15 (2002).
   PubMed Web of Science ®Google Scholar
• Ma Z, Meddings JB, Lee SS. Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats. Am. J. Physiol.267, 87–93 (1994).
   PubMed Web of Science ®Google Scholar
• Alqahtani SA, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Semin. Liver Dis.28, 59–69 (2008).
   PubMed Web of Science ®Google Scholar
• Ohkubo H, Okuda K, Iida S, Ohnishi K, Ikawa S, Makino I. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis. Gastroenterology86, 514–520 (1984).
   PubMedGoogle Scholar
• Desai MS, Shabier Z, Taylor M et al. Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis. Hepatology51, 2097–2107 (2010).
   PubMedGoogle Scholar
• Kaser S, Foger B, Waldenberger P et al. Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis. J. Hepatol.33, 902–906 (2000).
   PubMedGoogle Scholar
• Zierler K, Wu FS. Insulin acts on Na, K, and Ca currents. Trans. Assoc. Am. Physicians101, 320–325 (1988).
   PubMedGoogle Scholar
• Zhong J, Hwang TC, Adams HR, Rubin LJ. Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am. J. Physiol.273, H2312–H2324 (1997).
   Web of Science ®Google Scholar
• Guarner C, Soriano G, Tomas A et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology18, 1139–1143 (1993).
   PubMed Web of Science ®Google Scholar
• Navasa M, Follo A, Filella X et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology27, 1227–1232 (1998).
   PubMed Web of Science ®Google Scholar
• Haque R, Kan H, Finkel MS. Effects of cytokines and nitric oxide on myocardial E–C coupling. Basic Res. Cardiol.93, 86–94 (1998).
   PubMedGoogle Scholar
• Hendrickse MT, Triger DR. Peripheral and cardiovascular autonomic impairment in chronic liver disease: prevalence and relation to hepatic function. J. Hepatol.16, 177–183 (1992).
   PubMed Web of Science ®Google Scholar
• Trevisani F, Sica G, Mainquà P et al. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites. Hepatology30, 1387–1392 (1999).
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Bendtsen F, Hansen EF, Moller S. Acute nonselective β-adrenergic blockade reduces prolonged frequency adjusted QT interval in patients with cirrhosis. J. Hepatol.40, 239–246 (2004).
   PubMed Web of Science ®Google Scholar
• Zambruni A, Trevisani F, Di Micoli A et al. Effect of chronic β-blockade on QT interval in patients with liver cirrhosis. J. Hepatol.48, 415–421 (2008).
   PubMed Web of Science ®Google Scholar
• Edvardsson N, Olsson SB. Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man. Br. Heart J.45, 628–636 (1981).
   PubMedGoogle Scholar
• Kim YK, Hwang GS, Shin WJ, Bang JY, Cho SK, Han SM. Effect of propranolol on the relationship between QT interval and vagal modulation of heart rate variability in cirrhotic patients awaiting liver transplantation. Transplant. Proc.43, 1654–1659 (2011).
   PubMedGoogle Scholar
• Zambruni A, Di Micoli A, Bracci E et al. Acute gastrointestinal bleeding prolongs QT interval in cirrhosis. J. Hepatol.48, 125 (2008).
   PubMedGoogle Scholar
• Zingarelli B, Squadrito F, Altavilla D et al. Evidence for a role of nitric oxide in hypovolemic hemorrhagic shock. J. Cardiovasc. Pharmacol.19, 982–986 (1992).
   PubMed Web of Science ®Google Scholar
• Roumen RM, Hendriks T, van der Ven-Jongekrijg J et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg.218, 769–776 (1993).
   PubMed Web of Science ®Google Scholar
• Ward CA, Ma Z, Lee SS, Giles WR. Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis. Am. J. Physiol.273, G537–G544 (1997).
   PubMed Web of Science ®Google Scholar
• Conrath CE, Opthof T. Ventricular repolarization: an overview of (patho)physiology, sympathetic effects and genetic aspects. Prog. Biophys. Mol. Biol.92, 269–307 (2006).
   PubMed Web of Science ®Google Scholar
• Kass RS, Moss AJ, Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J. Clin. Invest.112, 810–815 (2003).
   PubMed Web of Science ®Google Scholar
• Kass RS, Wiegers SE. The ionic basis of concentration-related effects of noradrenaline on the action potential of calf cardiac purkinje fibres. J. Physiol.322, 541–558 (1982).
   PubMedGoogle Scholar
• Priori SG, Corr PB. Mechanisms underlying early and delayed after depolarizations induced by catecholamines. Am. J. Physiol.258, H1796–H1805 (1990).
   PubMed Web of Science ®Google Scholar
• Tan HL, Hou CJ, Lauer MR, Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann. Intern. Med.122, 701–714 (1995).
   PubMed Web of Science ®Google Scholar
• Al Sibae MR, Cappell MS. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Dig. Dis. Sci.56, 977–987 (2011).
   PubMed Web of Science ®Google Scholar
• Hansen S, Møller S, Bendtsen F, Jensen G, Henriksen JH. Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes. J. Hepatol.47, 373–380 (2007).
   PubMed Web of Science ®Google Scholar
• Sheehan J, Perry IJ, Reilly M et al. QT dispersion, QT maximum and risk of cardiac death in the Caerphilly Heart Study. Eur. J. Cardiovasc. Prev. Rehabil.11, 63–68 (2004).
   PubMedGoogle Scholar
• Stein LB, Dabezies MA, Silverman M, Brozena FC. Fatal torsade de pointes occurring in a patient receiving intravenous vasopressin and nitroglycerin. J. Clin. Gastroenterol.15, 171–174 (1992).
   PubMedGoogle Scholar
• Faigel DO, Metz DC, Kochman ML. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance. Am. J. Gastroenterol.90, 822–824 (1995).
   PubMedGoogle Scholar
• Nakasone H, Sugama R, Sakugawa H et al. Alcoholic liver cirrhosis complicated with torsade de pointes during plasma exchange and emodiafiltration. J. Gastroenterol.36, 564–568 (2001).
   PubMedGoogle Scholar
• Falagas ME, Rafailidis PI, Rosmarakis ES. Arrhythmias associated with fluoroquinolone therapy. Int. J. Antimicrob. Agents29, 374–379 (2007).
   PubMed Web of Science ®Google Scholar
• Urge J, Sincl F, Procházka V, Urbanek K. Terlipressin-induced ventricular arrhythmia. Scand. J. Gastroenterol.43, 1145–1148 (2008).
   PubMed Web of Science ®Google Scholar
• Di Micoli A, Zambruni A, Bracci E et al. ‘Torsade de pointes’ during amiodarone infusion in a cirrhotic woman with a prolonged QT interval. Dig. Liver Dis.41, 535–538 (2009).
   PubMedGoogle Scholar
• Chalasani N, Gorski JC, Patel NH, Hall SD, Galinsky RE. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts. Hepatology34, 1103–1108 (2001).
   PubMed Web of Science ®Google Scholar
• Vuppalanchi R, Juluri R, Ghabril M et al. Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt. J. Clin. Gastroenterol.45, 638–642 (2011).
   PubMedGoogle Scholar
• Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis. J. Hepatol.42(Suppl. 1), S85–S92 (2005).
   PubMedGoogle Scholar